CTRI/2024/04/065273
Not yet recruiting
Phase 4
Assessment of Metabolism mediated Pharmacokinetic Interactions and Therapeutic Potential of Chandraprabha vati with Glimepiride - Nil
SRM College of Pharmacy SRM Institute of Science and Technology0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- SRM College of Pharmacy SRM Institute of Science and Technology
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Willing to give informed written consent and comply with the study requirements
- •2 Subject should be able to communicate effectively
- •3 Non smokers or individuals who smoke less than 5 cigarettes per day
- •4 Teetotalers or individuals who drink less than 60 ml of high alcohol content liquor or 120 ml of low\-alcohol content liquor
- •5 Body Mass Index between 19 to 25
- •6 Healthy individuals as evaluated by personal history medical history and general clinical examination
- •7 BP should be within the range of 100 to 139 systolic and 60 to 89 diastolic Pulse rate should be within the range of 60 to 100 beats per minute Temperature between 97\.8 and 99\.0 degree Respiratory rate should be within the range of 14 to 18 breaths per minute
- •8 Normal biochemical hematological and urinary parameters
- •9 Normal Chest X ray
- •10 Negative for sexually transmitted diseases Hepatitis B Hepatitis C and Syphilis tests
Exclusion Criteria
- •1 Subjects incapable of understanding the informed consent
- •2 History of any major surgical procedure in the past 3 months
- •3 History of diabetes mellitus tuberculosis and systemic hypertension
- •4 History suggestive of cardiac gastrointestinal respiratory hepatic renal endocrine neurological metabolic psychiatric or haematological systems judged to be clinically significant
- •5 History of dysphagia
- •6 History of any medical disorder that is of significance in the investigators opinion
- •7 Present or past history of drug abuse
- •8 History of hypersensitivity to study formulation
- •9 History of allergy to vegetables and or food substances and or any other manifestations suggestive of hypersensitivity reactions
- •10 Present or past history of intake of drugs which potentially modify kinetics or dynamics of study medication or any other medication judged to be clinically significant by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of drug concentration according to genotype and inflammation by cardiopulmonary bypass surgeryDiseases of the circulatory systemKCT0008742Gachon University Gil Medical Center30
Active, not recruiting
Phase 1
Metabolic and Molecular Response Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal JunctioEUCTR2014-000860-16-DETechnische Universität München Fakultaet fuer Medizin120
Completed
Not Applicable
Pharmacokinetic and Metabolic Analysis of MaotoHealthy adultJPRN-UMIN000023609Kochi Medical School4
Active, not recruiting
Not Applicable
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
Not yet recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27